Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K McCormack

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Progress in Clinical and Biological Research|January 1, 1982
The use of Protein-A in the treatment of malignancy: rationale and the NCI experienceG L Messerschmidt, C Bowles, J Parrillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
A role for hydrophobic residues in the voltage-dependent gating of Shaker K+ channelsK McCormack, M A Tanouye, L E Iverson, et al.
Biochemical and Biophysical Research Communications|July 15, 1999
Multiple splicing variants of cdc25B regulate G2/M progressionA R Forrest, A K McCormack, C P DeSouza, et al.
European Journal of Human Genetics : EJHG|January 25, 2024
Identification of a DLG3 stop mutation in the MRX20 familyJolien Huyghebaert, Ligia Mateiu, Ellen Elinck, et al.
Journal of Huntington'S Disease|October 3, 2017
Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's DiseaseNicholas R Boileau, Julie C Stout, Janes S Paulsen, et al.
Journal of Huntington'S Disease|August 20, 2019
Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington DiseaseNoelle E Carlozzi, Siera Goodnight, Anna L Kratz, et al.
Journal of Huntington'S Disease|May 3, 2019
Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL OutcomesRebecca E Ready, Nicholas R Boileau, Stacey K Barton, et al.
Journal of Neurology|November 17, 2017
A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planningNoelle E Carlozzi, E A Hahn, S A Frank, et al.
Cancer Treatment Reports|December 1, 1982
Phase I trial of Staphylococcus aureus Cowan I immunoperfusionG Messerschmidt, C Bowles, D Dean, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|October 12, 2012
Evaluate, assess, treat: development and evaluation of the EAT framework to increase effective communication regarding sensitive oral-systemic health issuesR D DeBate, D Cragun, A A Gallentine, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Progress in Clinical and Biological Research|January 1, 1982
The use of Protein-A in the treatment of malignancy: rationale and the NCI experienceG L Messerschmidt, C Bowles, J Parrillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
A role for hydrophobic residues in the voltage-dependent gating of Shaker K+ channelsK McCormack, M A Tanouye, L E Iverson, et al.
Biochemical and Biophysical Research Communications|July 15, 1999
Multiple splicing variants of cdc25B regulate G2/M progressionA R Forrest, A K McCormack, C P DeSouza, et al.
European Journal of Human Genetics : EJHG|January 25, 2024
Identification of a DLG3 stop mutation in the MRX20 familyJolien Huyghebaert, Ligia Mateiu, Ellen Elinck, et al.
Journal of Huntington'S Disease|October 3, 2017
Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's DiseaseNicholas R Boileau, Julie C Stout, Janes S Paulsen, et al.
Journal of Huntington'S Disease|August 20, 2019
Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington DiseaseNoelle E Carlozzi, Siera Goodnight, Anna L Kratz, et al.
Journal of Huntington'S Disease|May 3, 2019
Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL OutcomesRebecca E Ready, Nicholas R Boileau, Stacey K Barton, et al.
Journal of Neurology|November 17, 2017
A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planningNoelle E Carlozzi, E A Hahn, S A Frank, et al.
Cancer Treatment Reports|December 1, 1982
Phase I trial of Staphylococcus aureus Cowan I immunoperfusionG Messerschmidt, C Bowles, D Dean, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|October 12, 2012
Evaluate, assess, treat: development and evaluation of the EAT framework to increase effective communication regarding sensitive oral-systemic health issuesR D DeBate, D Cragun, A A Gallentine, et al.
Pageof 11